✦ LIBER ✦

The current clinical management of Huntington's disease

✍ Scribed by Wendy Phillips; Kathleen M. Shannon; Roger A. Barker

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 225 KB
Volume: 23
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.21971

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Huntington's disease is a neurodegenerative condition, characterized by movement disorders, cognitive decline, and psychiatric disturbance. We review the pharmacological management of the various movement disorders associated with the disease, the cognitive decline and the commonly encountered behavioral disturbances. We discuss the nonclassical features of the disease, important in the management of these patients. Nonpharmacological support including genetic counseling and therapy and the importance of palliative care are also addressed. Finally, experimental approaches that may soon impact upon clinical practice are discussed. © 2008 Movement Disorder Society

📜 SIMILAR VOLUMES

Huntington's disease: Clinical and chemi

Huntington's disease: Clinical and chemical effects of choline administration

✍ Dr. John H. Growdon; Edith L. Cohen; Richard J. Wurtman 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 1 views

Clinical correlates of mitochondrial fun

Clinical correlates of mitochondrial function in Huntington's disease muscle

✍ Christopher Turner; J. Mark Cooper; Anthony H. V. Schapira 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

## Abstract Huntington's disease (HD) is caused by an abnormally expanded CAG repeat in the __IT__‐__15__ gene, which encodes a widely expressed protein called huntingtin. Abnormalities of mitochondrial respiratory chain function, specifically complex II/III, have been identified in HD striatum and

Clinical and genetic characteristics of

Clinical and genetic characteristics of Mexican Huntington's disease patients

✍ María Elisa Alonso; Adriana Ochoa; Marie-Catherine Boll; Ana Luisa Sosa; Petra Y 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB

## Abstract We report the characteristics of 691 Mexican patients with Huntington's disease (HD). These patients, representing 401 families, constitute the largest series of Mexican HD cases as yet described in the literature. We found the clinical characteristics of these patients to be similar to

Dystonia in Huntington's disease: Preval

Dystonia in Huntington's disease: Prevalence and clinical characteristics

✍ Elan D. Louis; Peter Lee; Lori Quinn; Karen Marder 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

## Background: The prevalence and clinical characteristics of dystonia in huntington's disease (hd) have not been formally assessed. ## Objectives: To study (1) the prevalence of dystonia in hd in a clinic population, (2) the clinical features of dystonia, and (3) clinical correlates of dystonia

Juvenile onset Huntington's disease?clin

Juvenile onset Huntington's disease?clinical and research perspectives

✍ Nance, Martha A. ;Myers, Richard H. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Abstract Huntington's disease (HD) is an inherited neurodegenerative disorder. The mutation which causes the disease is an expansion in the number of repetitions of three nucleotides, C, A, and G in exon 1 of the huntingtin gene. The gene normally has 15 to 30 repeats and an expansion to 40 or m

Huntington's disease phenocopies are cli

Huntington's disease phenocopies are clinically and genetically heterogeneous

✍ Edward J. Wild; Ese E. Mudanohwo; Mary G. Sweeney; Susanne A. Schneider; Jon Bec 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

## Abstract Huntington's disease (HD) classically presents with movement disorder, cognitive dysfunction and behavioral problems but is phenotypically variable. One percent of patients with HD‐like symptoms lack the causative mutation and are considered HD phenocopies. Genetic diseases known to cau